70% of autoimmune disease patients in India are women: Experts urge more awareness, better care

IMT News Desk
IMT News Desk
· 2 min read

Nearly 70% of autoimmune disease patients in India are women, and this alarming gender disparity demands urgent attention, according to leading rheumatologists at the 40th Annual Conference of the Indian Rheumatology Association (IRACON 2025). Autoimmune diseases—including conditions like rheumatoid arthritis, lupus, thyroiditis, psoriasis, and Sjogren’s syndrome—occur when the immune system mistakenly attacks the body’s own tissues, with symptoms ranging from joint pain to organ involvement.​

Experts highlighted a complex interplay of genetic, hormonal, and lifestyle factors making women, especially those aged 20 to 50, significantly more susceptible. Research from Stanford University reveals that a molecule called Xist RNA, active in women, may confuse the immune system, supporting what Indian doctors observe daily: seven out of ten autoimmune patients are women. Hormonal changes, genetic makeup, and the stresses of modern life further increase vulnerability.​

Social and environmental aspects worsen the problem. “Many women delay seeking help, dismissing pain or fatigue as minor issues,” said Dr Uma Kumar, Head of Rheumatology at AIIMS, New Delhi. Household and work responsibilities, combined with low awareness and cultural taboos, lead to late diagnoses, often after significant organ damage. Pollution and unhealthy lifestyles can also trigger or intensify autoimmune responses, noted Dr Neeraj Jain, Vice Chairman of Rheumatology at Sir Ganga Ram Hospital.

India faces a severe shortage of rheumatologists—fewer than 1,000 for over a billion people. Specialists at IRACON 2025 urged policy makers to recognize autoimmune illnesses as a major women’s health issue. They advocate for widespread awareness campaigns, routine screening, and training primary care physicians to recognize and refer symptoms early.​

“With 70% of those affected being women, we cannot ignore this disparity,” said Dr Rohini Handa, Senior Consultant at Indraprastha Apollo Hospitals. “Timely diagnosis, patient education, and inclusive health policy are crucial to tackle this growing epidemic.”​

Read Next

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg.
News
June 8, 2026

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg.

Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Haldol […]
Article by: IMT News Desk
Gastrointestinal and Liver Disorders Are Increasing: Dr. Chalapathi Rao Achanta
News
June 8, 2026

Gastrointestinal and Liver Disorders Are Increasing: Dr. Chalapathi Rao Achanta

Gastrointestinal and liver diseases are increasing as part of changing lifestyles, said Dr. Chalapathi Rao Achanta, Senior Consultant Gastroenterologist and Chairman of the Organizing Committee of the Gastro Update Conference, organized jointly by the Institute of Liver and Gastro Sciences at KIMS Hospitals, Seethammadhara, the Association of Physicians of India (API), the Indian Medical Association […]
Article by: IMT News Desk
Biorad Medisys Launches Compact Quantino 20W Laser System for Kidney Stone Management
News
June 8, 2026

Biorad Medisys Launches Compact Quantino 20W Laser System for Kidney Stone Management

Biorad Medisys announced the launch of Quantino 20W Thulium Fiber Laser for kidney stone management at UROLITHOCON 2026, the annual conference of the Urolithiasis Section of the Urological Society of India (USI) being held in Bengaluru. Studies suggest that nearly 12% of the Indian population is likely to develop kidney stones during their lifetime. Rising […]
Article by: IMT News Desk
Osteoarthritis is increasingly affecting people in their 30s; personalised treatment is the key: study
News
June 8, 2026

Osteoarthritis is increasingly affecting people in their 30s; personalised treatment is the key: study

Osteoarthritis (OA), long considered a wear-and-tear disease of old age, is increasingly being diagnosed in patients as young as 30 years, according to a review by researchers published in the journal International Orthopaedics. The review, published on May 15, reframes osteoarthritis as a heterogeneous syndrome rather than a single disease, driven by diverse biological, biomechanical, […]
Article by: IMT News Desk